ORIC Pharmaceuticals Inc

ORICNASDAQ · USD
12.54USD0.00 (+1.46%)
3210

ORIC Pharmaceuticals Inc (ORIC) Straddle

ORIC straddle scan found 57 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 62.5%.

Read more

Trading a ORIC straddle lets you take a pure volatility position on ORIC Pharmaceuticals Inc without committing to a direction. ORIC Pharmaceuticals Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ORIC straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on ORIC profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when ORIC Pharmaceuticals Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ORIC straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations.

The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the ORIC straddle is the cleanest expression of that view. Our scanner prices every ORIC straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ORIC straddle into a catalyst or short a ORIC straddle to harvest decay, the options straddle setups that matter are all in one place.

Feb 19, 202725.00$17.4015756%62.5%$42.40$7.600
Oct 16, 202615.00$4.433156%62.1%$19.43$10.581
Feb 19, 202724.00$16.9515756%60.4%$40.95$7.050
Feb 19, 202723.00$16.0515756%60.3%$39.05$6.950
Feb 19, 202722.00$15.4515756%58.8%$37.45$6.550
Oct 16, 202614.00$4.333156%58.0%$18.33$9.681
Feb 19, 202721.00$14.7315756%57.9%$35.73$6.280
Nov 20, 202618.00$8.956656%57.5%$26.95$9.050
Jan 15, 202721.00$13.7512256%57.2%$34.75$7.250
Nov 20, 202615.00$6.986656%56.2%$21.98$8.030

As of September 16, 2026

Find the right straddle before volatility moves

Track ORIC straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial